Created at	Source	Raw Value	Validated value
March 31, 2021, 12:31 a.m.	usa	Geometric Mean Fold Rise (GMFR) of SARS-CoV-2 Specific Neutralizing Antibody;Geometric Mean Titer (GMT) of SARS-CoV-2 Specific Neutralizing Antibody;Number of Participants Reporting Local and Systemic Adverse Events;Number of Participants Reporting Serious Events;Number of Participants Reporting Treatment-emergent Adverse Events;Seroconversion Rates of SARS-CoV-2 Specific Neutralizing Antibody	Geometric Mean Fold Rise (GMFR) of SARS-CoV-2 Specific Neutralizing Antibody;Geometric Mean Titer (GMT) of SARS-CoV-2 Specific Neutralizing Antibody;Number of Participants Reporting Local and Systemic Adverse Events;Number of Participants Reporting Serious Events;Number of Participants Reporting Treatment-emergent Adverse Events;Seroconversion Rates of SARS-CoV-2 Specific Neutralizing Antibody